helping your business succeed
Through comprehensive and experienced business and legal support
helping your business succeed
Through comprehensive and experienced business and legal support
About Us
Strategic professionals with extensive US and global experience and proven success
KCG's founding partners leverage their 80+ years of global industry and consulting experiences supporting some of the world's largest and most successful products, companies and business deals. On a project-by-project basis, we leverage a broad range of extensively experienced cross-functional experts. Each KCG Project Team is formed independently at the start of an engagement and confirmed by clients during the project scoping process.
Value we bring to our clients
We have helped our clients in the bio-pharmaceutical, medical device, diagnostic, healthcare, legal, oil, consulting, and investment banking industries achieve success building new product strategies, identifying values and risks, improve decision making, complete in-license deals and raise investment capital. Our legal consulting on contracts, intellectual property and expert witness services has been critical to corporate mergers, investor communications, and international legal proceedings.
Why choose Kondrad Consulting Group?
Our mission is to work side-by-side with our clients and help them succeed with confidence. KCGs’ relatively low overhead, limited client engagements and focused expert Project Teams allow us to provide maximum return on value, with quality and speed of investment for our clients.
services available
New Product Development
Corporate and Business Development and Licensing Support
New Product Development
- R&D, CMC, clinical, regulatory, payer and commercialization strategy.
- Critical decision support through primary & secondary market research and competitive intelligence with health care professionals and payers to support payer, pricing, market access, and reimbursement strategies.
- Target Product Profile (TPP) development and commercial
- R&D, CMC, clinical, regulatory, payer and commercialization strategy.
- Critical decision support through primary & secondary market research and competitive intelligence with health care professionals and payers to support payer, pricing, market access, and reimbursement strategies.
- Target Product Profile (TPP) development and commercial value forecasts.
- Product launch and go-to-market strategies.
- Professional medical conference support and KOL engagements.
Legal Support
Corporate and Business Development and Licensing Support
New Product Development
- Patent and trademark strategy and communications to support licensing and strategic partnering activities.
- Business or new product contract assessment and negotiations including IP licensing agreements.
- Contract strategy support for acquisitions or divestment of products and technologies.
- Experienced expert witness support in multiple therapeutic and business areas.
NOTE: KCG is not a law firm.
Corporate and Business Development and Licensing Support
Corporate and Business Development and Licensing Support
Corporate and Business Development and Licensing Support
- New product opportunity identification and evaluation.
- Target Product Profile, commercial value, forecast and indicative terms
- Deal Team leadership.
- Partnering support & Communications for in- and out-licensing and M&A.
- Due Diligence leadership, preparation, training, and execution.
- Project management for technology transfer; clinical, commer
- New product opportunity identification and evaluation.
- Target Product Profile, commercial value, forecast and indicative terms
- Deal Team leadership.
- Partnering support & Communications for in- and out-licensing and M&A.
- Due Diligence leadership, preparation, training, and execution.
- Project management for technology transfer; clinical, commercial, pharmacovigilance, CMC and payer.
- Alliance Management with partners.
- Contract / Agreement assessment and negotiation.
leadership team experience
Frank Kondrad, Managing Partner
A science-based business leader with a broad healthcare background. Frank has led projects in business strategy, new drug and device development, business development in/out-licensing, commercial brand and payer marketing, strategic planning and CMC regulatory readiness. He excels at primary and secondary market research and competitive intelligence areas.
Frank is a graduate of Philadelphia College of Pharmacy & Science and completed programs in pharmacology, business and leadership from Hahnemann Medical University, Wharton School of Business, INSEAD, and the Center for Creative Leadership.
His industry experiences include Senior VP of Corporate Development and Licensing for Epizon Pharma, Senior VP Corporate and Business Development for NeuroBo Pharmaceuticals, and Head of R&D Project Management for Shackelford Pharma. At AstraZeneca his experiences include Executive Director of Business Development and Licensing, Senior Director Clinical Development, Director of Managed Markets (Payer), Director of External Medical Relations, NEXIUM Managed Markets and HCP Brand Marketing Leader, CRESTOR Senior Market Research Manager, International Strategic Planning Manager (based in the UK) and Head of CMC Project Management and Regulatory Documentation and Senior Chemist.
Frank is a founding member of the Pharmaceutical Section of the Project Management Institute (PMI), member of; the Academy of Managed Care Pharmacy (AMCP), the European Society of Cardiology (ESC), the Licensing Executive Society (LES), has served on the Executive Industry Council of the Pharmaceutical Marketing Research Group (PMRG), and member of the Intellus Worldwide association for healthcare market research insights and analytics.
Karen Kondrad JD, Partner and General Counsel
A consulting intellectual property and contract business attorney with extensive global industry experience and broad background in due diligence, agreements, business development, licensing, intellectual property, and managing external counsel. Karen has helped clients with corporate business divestment contract reviews, IP strategy and investor communications, led IP contract negotiations for multi-billion-dollar acquisitions and divestment of commercial products, late and early stage R&D assets, and technologies and research collaborations with companies and universities. She has led successful litigation of IPR, EU patent challenges, global patent procurement and prosecution, licensing patent due diligence, and freedom-to-operate determinations.
Karen holds degrees in chemistry from the Philadelphia College of Pharmacy & Science and law from Widener University/Delaware Law School.
Her AstraZeneca, DuPont, and GlaxoSmithKline industrial positions include Principal Patent Attorney for Business Development and Licensing, Senior Patent Attorney, Chief Trademark Council, Assistant General Counsel (DuPont), and Medicinal Chemist (GSK).
Licensed and Admitted to the Pennsylvania, New Jersey and U.S. Federal Patent Bars and registered for Delaware's Rule 55.1. Karen also holds leadership roles on several local community boards.